Roche Holding AG
SIX:ROG
Roche Holding AG
Accounts Payable
Roche Holding AG
Accounts Payable Peer Comparison
Competitive Accounts Payable Analysis
Latest Figures & CAGR of Competitors
Company | Accounts Payable | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Roche Holding AG
SIX:ROG
|
Accounts Payable
CHf4.3B
|
CAGR 3-Years
2%
|
CAGR 5-Years
4%
|
CAGR 10-Years
7%
|
|
Novartis AG
SIX:NOVN
|
Accounts Payable
$4.1B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-3%
|
|
NLS Pharmaceutics AG
NASDAQ:NLSP
|
Accounts Payable
$2.4m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
33%
|
CAGR 10-Years
N/A
|
|
S
|
Sandoz Group AG
SIX:SDZ
|
Accounts Payable
$1.4B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Roche Holding AG's Accounts Payable?
Accounts Payable
4.3B
CHF
Based on the financial report for Dec 31, 2023, Roche Holding AG's Accounts Payable amounts to 4.3B CHF.
What is Roche Holding AG's Accounts Payable growth rate?
Accounts Payable CAGR 10Y
7%
Over the last year, the Accounts Payable growth was -5%. The average annual Accounts Payable growth rates for Roche Holding AG have been 2% over the past three years , 4% over the past five years , and 7% over the past ten years .